Epilog Partners is a private equity platform built by investors, operators and innovators for healthcares complexity. It invests in tech-enabled payer and provider services and software and tech-enabled pharma services companies that are improving clinical, financial, and experiential outcomes. Epilog targets equity investments of $50 to $200 million in leveraged buyouts of profitable, high-growth companies. Its efforts are guided by a research centric, thesis driven approach that informs where to invest and how to maximize value. This approach has resulted in completed platform investments, add-on acquisitions, recapitalizations and liquidity events with an aggregate transaction value of over $6 billion. Portfolio Companies: Care Connectors, CareMetx and ReceptRx (exited)
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
What industry is Epilog Partners in?
Epilog Partners operates in Venture Capital and Private Equity Principals. Find similar Venture Capital and Private Equity Principals investors on gritt.io.
Where is Epilog Partners based?
Epilog Partners is headquartered in Dallas, United States.